Skip to main content
. 2024 Jul 31;103(4):e209700. doi: 10.1212/WNL.0000000000209700

Table 1.

Baseline Characteristics of the Total Rotterdam Study Population, Including Individuals With and Without Migraine

Total study population All (n = 7,266) With (a history of) migraine (n = 1,085) Without (a history of) migraine (n = 6,181)
Aura (%) 221 (3.0) 221 (20.4)
Female (%) 4,181 (57.5) 884 (81.5) 3,297 (53.3)
Age (y) 66.6 [56.4−74.8] 62.2 [55.5−72.8] 66.9 [56.5−75.2]
Education level (%)
 Primary education 692 (9.5) 100 (9.2) 592 (9.6)
 Lower/intermediate general education or lower vocational education 2,906 (40.0) 490 (45.2) 2,416 (39.1)
 Intermediate vocational education or higher general education 2,114 (29.1) 273 (25.2) 1841 (29.8)
 Higher vocational education or university 1,554 (21.4) 222 (20.5) 1,332 (21.5)
BMI (kg/m2) 27.1 [24.7−29.9] 27.3 [24.5−30.1] 27.0 [24.7−29.9]
Obesity (BMI >30 kg/m2) (%) 1764 (24.3) 276 (25.4) 1,488 (24.1)
Waist-to-hip ratio 0.88 [0.82−0.95] 0.86 [0.80−0.91] 0.89 [0.83−0.95]
Systolic blood pressure (mm Hg) 139 [125−155] 138 [124−154] 140 [126−156]
Diastolic blood pressure (mm Hg) 83 [76−91] 83 [77−91] 83 [76−91]
Hypertension (%) 4,963 (68.3) 720 (66.4) 4,243 (68.6)
Antihypertensive drug use (%) 2,960 (40.7) 435 (40.1) 2,525 (40.9)
Total cholesterol (mmol/L) 5.4 [4.8−6.2] 5.6 [4.9−6.3] 5.4 [4.7−6.1]
High-density lipoprotein cholesterol (mmol/L) 1.4 [1.2−1.7] 1.5 [1.2−1.8] 1.4 [1.1−1.7]
Triglycerides (mmol/L) 1.3 [1.0−1.7] 1.3 [1.0−1.8] 1.3 [1.0−1.7]
Hypercholesterolemia (%) 3,590 (49.4) 556 (51.2) 3,034 (49.1)
Lipid-lowering medication use (%) 1979 (27.2) 288 (26.5) 1,691 (27.4)
Fasting glucose levels (mmol/L) 5.4 [5.0−5.9] 5.3 [5.0−5.8] 5.4 [5.1−5.9]
Diabetes mellitus (%) 857 (11.8) 101 (9.3) 756 (12.2)
Smoking status (%)
 Former 3,601 (49.6) 532 (49.0) 3,069 (49.7)
 Current 1,277 (17.6) 159 (14.7) 1,118 (18.1)
Pack-years of ever smokers 16.8 [6.0−33.0] 12.5 [3.5−28.7] 17.5 [6.3−33.8]
Alcohol consumption (gram/day) 6.4 [0.5−8.6] 3.8 [0.5−8.6] 6.4 [0.5−8.6]
Physical activity (MET hours/week) 37.3 [15.0−75.6] 39.2 [15.2−74.5] 37.1 [15.0−75.7]

Abbreviations: BMI = body mass index; MET = metabolic equivalent of task.

Note: Imputed and unadjusted values of the cohort, with and without stratification for the migraine diagnosis, are displayed as means (SD) or medians [interquartile range, Q3–Q1] or as numbers (percentage). Anderson-Darling normality test was used to assess normality.

Missing values of variables before imputation: smoking status: 0.04%; alcohol consumption: 0.22%; antihypertensive drug use: 0.45%; lipid-lowering drug use: 0.45%; antidiabetic drug use: 0.45%; educational level: 0.88%; BMI: 6.76%; systolic BP: 8.02%; diastolic BP: 8.02%; total cholesterol: 8.55%; glucose: 8.56%; high-density lipoprotein cholesterol: 8.75%; waist-to-hip ratio: 9.01%; triglycerides: 9.47%; and physical activity: 18.54%.